| scholarly article | Q13442814 |
| P356 | DOI | 10.1158/1078-0432.CCR-08-1369 |
| P698 | PubMed publication ID | 19047110 |
| P2093 | author name string | Hsuan-Ying Huang | |
| Chien-Feng Li | |||
| Tsung-Hui Hu | |||
| Ching-Nan Lin | |||
| Yih-Huei Uen | |||
| Fu-Min Fang | |||
| David Lu | |||
| Shih-Chen Yu | |||
| Wen-Wei Huang | |||
| Jing-Mei Wu | |||
| Yu-Fang Tian | |||
| P433 | issue | 23 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | overexpression | Q61643320 |
| P304 | page(s) | 7822-7831 | |
| P577 | publication date | 2008-12-01 | |
| P1433 | published in | Clinical Cancer Research | Q332253 |
| P1476 | title | Heat shock protein 90 overexpression independently predicts inferior disease-free survival with differential expression of the alpha and beta isoforms in gastrointestinal stromal tumors | |
| P478 | volume | 14 |
| Q35098333 | A first-in-human phase I, dose-escalation, multicentre study of HSP990 administered orally in adult patients with advanced solid malignancies |
| Q34957349 | AMACR amplification and overexpression in primary imatinib-naïve gastrointestinal stromal tumors: a driver of cell proliferation indicating adverse prognosis |
| Q43463170 | Alterations of the Hsp70/Hsp90 chaperone and the HOP/CHIP co-chaperone system in cancer. |
| Q36556257 | Autophagy is involved in endogenous and NVP-AUY922-induced KIT degradation in gastrointestinal stromal tumors. |
| Q39002157 | Chiral resolution and pharmacological characterization of the enantiomers of the Hsp90 inhibitor 2-amino-7-[4-fluoro-2-(3-pyridyl)phenyl]-4-methyl-7,8-dihydro-6H-quinazolin-5-one oxime |
| Q48113104 | Cooperation between Hsp90 and mortalin/GRP75 in resistance to cell death induced by complement C5b-9. |
| Q39416581 | Differences in the frequencies of K-ras c12-13 genotypes by gender and pathologic phenotypes in colorectal tumors measured using the allele discrimination method |
| Q92617688 | Differential expression of HSP90 isoforms and their correlations with clinicopathologic factors in patients with colorectal cancer |
| Q33915037 | Effect of the secretory small GTPase Rab27B on breast cancer growth, invasion, and metastasis |
| Q39817880 | Ezrin overexpression in gastrointestinal stromal tumors: an independent adverse prognosticator associated with the non-gastric location |
| Q37690758 | Hsp90 as a therapeutic target in patients with oesophageal carcinoma |
| Q57285756 | Hsp90ab1 stabilizes LRP5 to promote epithelial-mesenchymal transition via activating of AKT and Wnt/β-catenin signaling pathways in gastric cancer progression |
| Q47929181 | HuR cytoplasmic expression is associated with increased cyclin A expression and inferior disease-free survival in patients with gastrointestinal stromal tumours (GISTs). |
| Q58558239 | Hydroxysteroid 11-Beta Dehydrogenase 1 Overexpression with Copy-Number Gain and Missense Mutations in Primary Gastrointestinal Stromal Tumors |
| Q37813454 | Molecular basis for primary and secondary tyrosine kinase inhibitor resistance in gastrointestinal stromal tumor |
| Q41984466 | Overexpression of DJ-1 and HSP90α, and loss of PTEN associated with invasive urothelial carcinoma of urinary bladder: Possible prognostic markers |
| Q33785608 | Protein signature for non-small cell lung cancer prognosis |
| Q34170410 | Proteomic analyses reveal high expression of decorin and endoplasmin (HSP90B1) are associated with breast cancer metastasis and decreased survival |
| Q34804754 | Selecting tyrosine kinase inhibitors for gastrointestinal stromal tumor with secondary KIT activation-loop domain mutations |
| Q27851619 | The Hsp90 inhibitor IPI-504 rapidly lowers EML4-ALK levels and induces tumor regression in ALK-driven NSCLC models |
| Q37580351 | Transcriptomic reappraisal identifies MGLL overexpression as an unfavorable prognosticator in primary gastrointestinal stromal tumors |
Search more.